Koyfin Home > Directory > Health Care > Aduro Biotech > EV / Sales (ntm)

Aduro Biotech EV / Sales (ntm) Chart (ADRO)

Aduro Biotech annual/quarterly EV / Sales (ntm) from 2015 to 2020.
  • Aduro Biotech EV / Sales (ntm) for the quarter ending September 09, 2020 was 9.09 a 4.79% increase of 0.44 year over year
  • Aduro Biotech EV / Sales (ntm) for the last 12 months ending September 09, 2020 was 9.09 a 4.79% increase of 0.44 year over year
  • Aduro Biotech Annual EV / Sales (ntm) for 2020 was 9.09 a -0.80% decrease of -0.07 from 2019
  • Aduro Biotech Annual EV / Sales (ntm) for 2020 was 9.16 a -37.25% decrease of -3.41 from 2019
  • Aduro Biotech Annual EV / Sales (ntm) for 2020 was 12.57 a 31.18% increase of 3.92 from 2019
Other Valuation Metrics:
  • Aduro Biotech Market Cap for the quarter ending March 03, 2018 was $753m a -5.79% decrease of -44m year over year
  • Aduro Biotech Price / Book for the quarter ending March 03, 2018 was 3.04 a -14.05% decrease of -0.43 year over year
  • Aduro Biotech Enterprise Value for the quarter ending March 03, 2018 was $427m a -3.70% decrease of -16m year over year
View Chart On Koyfin

Quarterly ADRO EV / Sales (ntm) Data

09/20209.09
09/20209.16
09/202012.57
09/20208.65
09/202010.40
09/20207.56
09/20207.49
09/20206.77
09/20204.69
09/20207.98

Annual ADRO EV / Sales (ntm) Data

20209.09
20209.16
202012.57
20208.65
202010.40
20207.56
20207.49
20206.77
20204.69
20207.98